CG Oncology CGON
NASDAQ CGON
$74.43 +0.10 (+0.13%)
As of: Sep 4, 2026 · 2:36 PM EDT

CG Oncology (CGON) Price to Earnings (2024 - 2026)

Analysis

CG Oncology (CGON) Price to Earnings (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 CG Oncology 6.56 Bn 6.56 Bn -2.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -79.35
Mar 31, 2026 -99.11
Dec 31, 2025 -81.21
Sep 30, 2025 -72.14
Jun 30, 2025 -47.85
Mar 31, 2025 -54.17
Dec 31, 2024 -56.37
Sep 30, 2024 -124.88
Jun 30, 2024 -111.33
Mar 31, 2024 -122.03